top of page
The Human Variable
Search


The Diagnostic Acceleration Blueprint ™ : How to Cut Diagnostic Timelines by 95% and Costs by 99%
The Diagnostic Acceleration Blueprint™ modernizes IACC diagnostics by combining reuse-first biospecimen pipelines, digital consent, and ML-driven multi-system fingerprints. This framework cuts timelines by 95%, costs by 99%, and eliminates multi-year delays rooted in outdated systems.
Nov 19, 2025


Composite Diagnostic Fingerprint for POTS
CDF-POTS is a new AI powered diagnostic fingerprint that captures the hidden patterns of POTS across cognitive, cardiac, vascular, and orthostatic domains. An estimated 16.5M Americans are living with POTS, most without a formal diagnosis. This model removes diagnostic waste by 86 percent, cuts ER visits by 70 percent, and restores workforce participation while saving the United States up to 400B dollars annually.
Nov 18, 2025


The Unified Network Collapse Theory (UNCT™)
Chronic, multisystem collapse following infectious, environmental, or immunological insult has become one of the defining biomedical failures of the twenty-first century. The Unified Network Collapse Theory (UNCT™) reframes ME/CFS, Long COVID, POTS, MCAS, autoimmune destabilization, and post-vaccination or post-surgical syndromes as diversified expressions of a single systems-failure mode: Neuro-Immune-Autonomic Network Collapse. This framework is supported by decades of frag
Nov 14, 2025


The Antiviral Pairing Logic (APL) Framework: Terrain Stabilization with Antiviral Clearance for Long COVID Remission
The Antiviral Pairing Logic framework synthesizes longitudinal field analysis across more than two hundred patient trajectories with in silico terrain modeling and real-world pharmacology. Durable response consistently follows three preconditions: immune stabilization to prevent cytokine rebound, mast cell and autonomic modulation before viral clearance, and energy and vascular repair after antigen reduction.
Nov 13, 2025


CYNAERA REPURPOSED™: AI Driven Fast Track Drug Repurposing for Infection Associated Chronic Conditions
CYNAERA REPURPOSED™ accelerates drug discovery for infection-associated chronic conditions like Long COVID and ME/CFS. Using AI-driven terrain modeling, it cuts repurposing timelines from years to weeks—identifying multi-indication therapies, reducing cost by up to 90%, and advancing patient-ready treatments through intelligent simulation.
Nov 5, 2025


Remission Pathways in ME/CFS: Drug Combinations, Chronicity & Socio-Biologic Terrain
Remission in ME/CFS is often described as spontaneous, yet nothing about it is random. The illusion of rarity comes from measurement bias. We record symptoms, not trajectory. When patient data is plotted longitudinally rather than episodically, a clear pattern emerges. Remission occurs when the body’s internal feedback systems, immune, autonomic, and metabolic, temporarily synchronize
Oct 19, 2025
bottom of page
